The University of Göttingen, officially the Georg August University of Göttingen, is a public research university in the city of Göttingen, Germany.

During the past decade, University of Göttingen conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Göttingen" #1 sponsor was "Florian Lordick, MD" with 1 trials, followed by "Heidelberg University" with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored, "Klaus Herfarth, MD" with 1 trials sponsored and "University of Göttingen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Göttingen" #1 collaborator was "Centre de Recheche du Centre Hospitalier Université Laval" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo" with 1 trials as a collaborator, "Institut Pasteur de Dakar" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "University of Göttingen" are "Cancer Disease, Palliative Therapy" (1 trials), "Central Venous Catheterization" (1 trials), "Chikungunya Fever" (1 trials), "Critical Care" (1 trials) and "Dengue Fever" (1 trials). Many other conditions were trialed in "University of Göttingen" in a lesser frequency.

Most popular intervention types in "University of Göttingen" are "Drug" (3 trials), "Device" (1 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Central venous catheter placement" (1 trials), "Chest radiography" (1 trials), "Differential RPA tests" (1 trials), "Experimental" (1 trials) and "Point of care echocardiography" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Göttingen" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Göttingen". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Göttingen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Göttingen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".